P006224 revised AU-VU:EOAS Encyclopedia of Australian Science and Innovation

All key entry types: Awards; Concepts; Corporate Bodies (Organisations); Cultural Artefacts; People; etc

These key entries are listed separately below with other indexes and lists.

 English AACR2 Anglo-American Cataloguing Rules Corporate Body created 2019-01-22 human Elizabeth Daniels updated 2024-05-10 human https://www.eoas.info/biogs/P006224b.htm corporateBody Cell Therapies Pty Ltd AACR2 CTPL 2003 Cell Therapies Pty Ltd (CTPL) was established in 2003, the company manufactures and distribute cell-based therapies to the Australian and the International medical and scientific community. CTPL has a specific interest in apheresis site management and a close relationship with the Peter MacCallum Cancer Centre was a founding and is a majority shareholder in the company. Melbourne Biomedical Precinct Office (c. 2019 - )

Cell Therapies Pty Ltd is a partner of the Melbourne Biomedical Precinct.

 Peter MacCallum Cancer Institute (1986 - )

The Peter MacCallum Cancer Institute was a founding, and is a majority, shareholder in Cell Therapies Pty Ltd. The two are also close research partners.

 'Cell Therapies Pty Ltd', in Encyclopedia of Australian Science and Innovation, Centre for Transformative Innovation, Swinburne University of Technology Cell Therapies Pty Ltd Swinburne University of Technology, Centre for Transformative Innovation Encyclopedia of Australian Science and Innovation Resource Section: Peter MacCallum Cancer Centre Peter MacCallum Cancer Centre Cell Therapies Pty Ltd Cell Therapies Resource Section: About About Cell Therapies Pty Ltd 2019 Cell Therapies